Morning Trend | WAI CHUN BIOTEC funds gradually entering the market, can short-term recovery create space?

WAI CHUN BIOTEC saw active capital entry yesterday, with its pharmaceutical defensive attributes becoming the market focus. Throughout the day, the intraday trend gently rose, and market expectations for the sector's right-side recovery increased. The approval fees for innovative drugs in the pharmaceutical industry are expected to be reduced, which has reversed the previous capital pressure and attracted short-term attention to some quality small-cap stocks. In terms of technical performance, short-term moving averages have stopped declining and are trending upwards, with increased capital accumulation at low levels. Although the main force has not expanded to an explosive level, it has significantly warmed compared to last week. The investment community is actively discussing the pharmaceutical sector's economic moat, with increased recognition of safety cushions in a volatile pattern. If the intraday trend continues to rise, there may be short-term elasticity, but high-level pressure remains, and when the sector overall slows down, chasing high prices may lead to profit-taking. During the trading session, it is essential to pay close attention to the main force's unusual movements and industry capital rotation, with operations primarily focused on buying low and selling high, and dynamic position management